CD8A and metabolic disease: These results imply that PLA2G16-mediated C24:4 (n-6) accumulation in the lung acts as a metabolic disorder to CD8<sup>+</sup> T cell antitumor activity and highlights a critical role of PLA2G16 in promoting TNBC lung metastasis.